REG - Indivior PLC - Director/PDMR Shareholding

IndiviorAnnouncement

06/08/2019 14:00

RNS Number : 1156I
Indivior PLC
06 August 2019
 


INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM
The Company announces that it received notification on August 6, 2019 that Mark Crossley, Chief Financial and Operations Officer, acquired 63,291 shares at a price of $0.7314 per share.
Following this transaction, Mark Crossley has an interest in 346,663 shares in the Company.
 



1


Details of the person discharging managerial responsibilities / person closely associated


 




a)
 


Name
 
 


Mark Crossley


 




2
 


Reason for the notification
 


 




a)
 


Position/status
 
 


Chief Financial and Operations Officer


 




b)
 


Initial notification /Amendment
 
 


Initial notification


 




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 


 




a)
 


Name
 
 


Indivior PLC


 




b)
 


LEI
 
 


213800V3NCQTY7IED471


 




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
  


 




a)
 


Description of the financial instrument, type of instrument
 
Identification code
  


Ordinary Shares of US$0.10
 
 
 
ISIN:  GB00BRS65X63
 
Ticker: IZQVF


 




b)
 


Nature of the transaction
  


Purchase of shares
 


 




c)
 


Price(s) and volume(s)
 
 


 



Price(s)


Volume(s)




US$ 0.7314


63,291



  


 




d)
 


Aggregated information
 
- Aggregated volume
 
 
- Price
 


 
N/A
 
 
 
 


 




e)
 


Date of the transaction
  


August 6, 2019


 




f)
 


Place of the transaction
 


OTC Market in the USA


 



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUGUBPRUPBGGQ